World-Class Care with Heart




Rheumatology Research

This listing changes frequently.  For more information about the trials we have available, please contact us at (551) 996-5627 or via e-mail pedsresearch@HackensackUMC.org 
 
Pro00002091
Jennifer Weiss, MD
PR-COIN (Pediatric Rheumatology-Care and Outcomes Improvement Network)
 
20120604 / III
Jennifer Weiss, MD

Protocol RA0043:  A Multicenter, Open-Label Study to Assess the Pharmacokinetics, Safety, and Efficacy of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Polyarticular-Course Juvenile Idiopathic Arthritis (Pascal Study)
 
Pro00001481
Jennifer Weiss, MD
CARRA (Childhood Arthritis and Rheumatology Research Alliance) Registry
 
Pro00001481
Jennifer Weiss, MD

Childhood Onset Rheumatoid Arthritis (CORA) Carra Registry Substudy
 
Pro00004906
Jennifer Weiss, MD

Spondyloarthritis Microbiota Study
 
20140833
Jennifer Weiss, MD

WA29231-Jigsaw Extension Study-Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients With Polyarticular Course and Systemic Juvenile Idiopathic Arthritis
 
05.02.048 / IV
Suzanne Li, MD

Development of Autoimmunity During Puberty in SLE
 
07.02.055 / IV
Suzanne Li, MD

Development of Clinical and Ultrasound Measures for Pediatric Localized Scleroderma-Locus 2
 
Pro00002284 / IV
Suzanne Li, MD

Evaluating Quality of Life in Pediatric Rheumatology Patients
 
06.02.118
Suzanne Li, MD

A Project Towards Establishment of a US/Canadian Diagnostic Registry of Children With Chronic Vasculitis (ARCHIVE, A Registry for Children With Vasculitis: e-entry) (Peds Vasculitis)
 
20122020 / II
Suzanne Li, MD

A Phase IIa, International, Multicenter, Open-Label, Uncontrolled Study to Evaluate the Safety and Pharmacokinetics of 4 x 375 mg/m2 Intravenous Rituximab in Pediatric Patients With SEVERE Granulomatosis With Polyangiitis (Wegener’s) and Microscopic Polyangiitis (Rituximab-Vasculitis)
 
Pro00004269
Yukiko Kimura, MD

The Learning Cohort (TLC): BCH R01 Overview-Carra Registry Substudy
 
20111760 / I
Yukiko Kimura, MD

A Phase I Pharmacokinetic and Safety Study of Tocilizumab (TCZ) in Patients Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) (NP25737)
 
Pro00003867
Kathleen Haines, MD

A Registry of Patients With Primary Immunodeficiency Disorder
 
20130533 / I
Ginger Janow, MD

A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Polyarticular-Course Juvenile  Idiopathic Arthritis WA28117
 
20130534 / I
Ginger Janow, MD

A Phase Ib, Open-Label, Multicenter Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of Tocilizumab Following Subcutaneous Administration to Patients With Systemic Juvenile Idiopathic Arthritis WA28118
 


best-hospitals-cardiology    high-performing-indicator-heartfailure    high-performing-indicator-heartbypass     HG_Americas_50_Best_Award_Image_2014      HG_Americas_100_Best_Stroke_Care_Award_Image_2014        HG_Americas_100_Best_Pulmonary_Care_Award_Image_2014     red-bulllgbt      tkc_homepagelogo-2
 


Translation service provided by Google. Hackensack University Medical Center is not responsible for the accuracy of translation or any other
aspect of service provided by the GoogleTranslate tool. Users should not make medical decisions without first consulting
with their physician.
 
Site Map|Privacy Policy|Media Center
©2017 Hackensack University Medical Center. All rights reserved.
close (X)